Complement 2 deficiency
human disease
Complement 2 deficiency is a type of complement deficiency caused by any one of several different alterations in the structure of complement component 2.
It has been associated with an increase in infections.
It can present similarly to systemic lupus erythematosus (SLE).
Signs and symptoms
C2D is linked to bacterial infections, especially encapsulated bacterial infections, as well as a risk of Systemic Lupus Erythematosus (SLE) or SLE-like disease.
Complement deficiency has historically been associated with early, severe bacterial infections among children. Infection susceptibility is frequently observed.
C2D is linked to abnormalities in serum immunoglobulin levels, such as lower IgG2 and IgG4 levels, which could contribute to raised infection susceptibility. More than half of 40 C2D patients in a study had Streptococcus pneumoniae-related invasive infection, primarily meningitis or sepsis. Haemophilus influenza type b and Neisseria meningitis are two other infections commonly seen in C2D patients.
Complications
In roughly 10% of patients, a C2 deficiency is linked to an illness that resembles SLE. Clinical manifestations of this SLE-like illness include fever, rash, arthritis, and glomerulonephritis.
“Complement 2 deficiency” enters the record as human disease. Crown Archives preserves that source wording while asking what Complement, deficiency and human can confirm, complicate or overturn.
Why this record matters
“Complement 2 deficiency” is worth following because a concise public description often conceals a longer documentary argument. Here, Complement, deficiency and human provides the most credible route into that argument.
Vocabulary and entity names are the principal evidence signals here, because they determine the precision of every later search. The source revision retrieved here is dated Jul 17, 2025. The linked authority identifier is Q5156399.
Overview language is designed for orientation and should not be treated as a substitute for the evidence cited beneath it. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “Complement 2 deficiency”, its source revision and the description used here.
- Expand the search: follow Complement 2 deficiency primary sources, Complement 2 deficiency archive and Complement research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Complement 2 deficiency”?
- Which cited source is closest to the event, object or claim?
- Which institution is responsible for the underlying evidence?
Search terms from this dossier
This entry incorporates text from “Complement 2 deficiency” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.